CN Patent

CN103848829B — 杂芳基炔烃化合物及其应用

Assigned to Nanjing Sanhome Pharmaceutical Co Ltd · Expires 2017-04-12 · 9y expired

What this patent protects

本发明属于化学医药领域。具体提供了一类具有杂芳基炔烃结构的化合物或其盐、立体异构体、N‑氧化物、溶剂合物或前药，可以抑制Bcr‑Abl和SRC等多个靶点，并能够对T315I突变耐药酶具有较好抑制活性。本发明还提供了其在制备治疗或预防肿瘤药物中的应用。

USPTO Abstract

本发明属于化学医药领域。具体提供了一类具有杂芳基炔烃结构的化合物或其盐、立体异构体、N‑氧化物、溶剂合物或前药，可以抑制Bcr‑Abl和SRC等多个靶点，并能够对T315I突变耐药酶具有较好抑制活性。本发明还提供了其在制备治疗或预防肿瘤药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN103848829B
Jurisdiction
CN
Classification
—
Expires
2017-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.